Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intranasal oxytocin on social approach in social phobia and healthy controls
2009-015538-30Phase 4Completed
- Sponsor
- RWTH Aachen University
- Start
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of oxytocin in Social Anxiety Disorder (SAD) (2 arms), sponsored by RWTH Aachen University. Primary endpoint: Social approach behavior change. Started Feb 2010; status: completed.
02
Drugs
oxytocin
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on 2009-015538-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015538-30.